Joseph Jimenez
Chairman at CENTURY THERAPEUTICS, INC.
Net worth: 8 M $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark Fishman | M | 73 |
Aditum Bio Fund 1 LP
 Aditum Bio Fund 1 LP Investment ManagersFinance Aditum Bio Fund 1 LP specializes in acquiring and developing pharmaceutical assets. The company is headquartered in San Mateo, CA.
Teres Bio, Inc.
 Teres Bio, Inc. Pharmaceuticals: MajorHealth Technology Teres Bio, Inc. operates as a clinical stage life sciences company. It translates discoveries in inflammatory pathways into novel, topical therapies for atopic dermatitis and plaque psoriasis skin diseases. The company is headquartered in Oakland, CA.
Anteris Bio, Inc.
 Anteris Bio, Inc. Pharmaceuticals: MajorHealth Technology Anteris Bio, Inc. develops therapies for the treatment of renal disease. The company is based in Oakland, CA. The CEO of the company is Ilan Zipkin.
Versanis Bio, Inc.
 Versanis Bio, Inc. BiotechnologyHealth Technology Part of Eli Lilly & Co., Versanis Bio, Inc. is a clinical-stage biopharmaceutical company. The company is based in New York, NY. The company was founded by Lloyd Klickstein. Mark E. Pruzanski has been the CEO of the company since 2021. Versanis Bio was acquired by Eli Lilly & Co. on August 14, 2023 for $1,925 million. | 5 years |
| Jon Moeller | M | 59 | 36 years | |
| Mary Barra | F | 61 | 44 years | |
| Hans Jörg Reinhardt | M | 68 | 40 years | |
| Lloyd Klickstein | M | 67 |
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Part of Eli Lilly & Co., Versanis Bio, Inc. is a clinical-stage biopharmaceutical company. The company is based in New York, NY. The company was founded by Lloyd Klickstein. Mark E. Pruzanski has been the CEO of the company since 2021. Versanis Bio was acquired by Eli Lilly & Co. on August 14, 2023 for $1,925 million. | 3 years |
| Donald Emil Ganem | M | - |
Via Nova Therapeutics, Inc.
 Via Nova Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Via Nova Therapeutics, Inc. is a company that aims to discover and develop safe and effective therapies for viral diseases with inadequate treatments. The company is based in Oakland, CA. Via Nova's pipeline includes four programs targeting influenza, human rhinovirus, polyomavirus, and adenovirus. The company is committed to advancing this initial pipeline with additional discovery efforts to follow. Via Nova believes that the recent expansion of point-of-care testing and telemedicine driven by the COVID-19 pandemic will transform the diagnostic landscape, allowing early recognition of all the important respiratory viruses. The company was founded in August 2021 and has in-licensed antiviral programs from RTIs. The CEO of the company is Donald Emil Ganem. | - |
| Douglas Carr | M | - | 6 years | |
| Kim Stratton | F | 62 |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | 4 years |
| Gregory Russotti | M | 57 | 4 years | |
| Benjamine Liu | M | - |
Anteris Bio, Inc.
Anteris Bio, Inc. Pharmaceuticals: MajorHealth Technology Anteris Bio, Inc. develops therapies for the treatment of renal disease. The company is based in Oakland, CA. The CEO of the company is Ilan Zipkin.
Teres Bio, Inc.
Teres Bio, Inc. Pharmaceuticals: MajorHealth Technology Teres Bio, Inc. operates as a clinical stage life sciences company. It translates discoveries in inflammatory pathways into novel, topical therapies for atopic dermatitis and plaque psoriasis skin diseases. The company is headquartered in Oakland, CA.
Via Nova Therapeutics, Inc.
Via Nova Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Via Nova Therapeutics, Inc. is a company that aims to discover and develop safe and effective therapies for viral diseases with inadequate treatments. The company is based in Oakland, CA. Via Nova's pipeline includes four programs targeting influenza, human rhinovirus, polyomavirus, and adenovirus. The company is committed to advancing this initial pipeline with additional discovery efforts to follow. Via Nova believes that the recent expansion of point-of-care testing and telemedicine driven by the COVID-19 pandemic will transform the diagnostic landscape, allowing early recognition of all the important respiratory viruses. The company was founded in August 2021 and has in-licensed antiviral programs from RTIs. The CEO of the company is Donald Emil Ganem. | - |
| Ilan Zipkin | M | - |
Anteris Bio, Inc.
Anteris Bio, Inc. Pharmaceuticals: MajorHealth Technology Anteris Bio, Inc. develops therapies for the treatment of renal disease. The company is based in Oakland, CA. The CEO of the company is Ilan Zipkin.
Via Nova Therapeutics, Inc.
Via Nova Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Via Nova Therapeutics, Inc. is a company that aims to discover and develop safe and effective therapies for viral diseases with inadequate treatments. The company is based in Oakland, CA. Via Nova's pipeline includes four programs targeting influenza, human rhinovirus, polyomavirus, and adenovirus. The company is committed to advancing this initial pipeline with additional discovery efforts to follow. Via Nova believes that the recent expansion of point-of-care testing and telemedicine driven by the COVID-19 pandemic will transform the diagnostic landscape, allowing early recognition of all the important respiratory viruses. The company was founded in August 2021 and has in-licensed antiviral programs from RTIs. The CEO of the company is Donald Emil Ganem. | - |
| Gagan Sawhney | M | 48 | - | |
| Alessandro Riva | M | 63 | 15 years | |
| Frans van Houten | M | 64 | 7 years | |
| Amy Chang | F | 47 | 7 years | |
| Bertrand-Marc Allen | M | 50 | 3 years | |
| Mark Tatum | M | 54 | 3 years | |
| Tom Henderson | M | - | - | |
| Derek de la Mater | M | 57 | 31 years | |
| Daphne Quimi | F | 58 | 2 years | |
| Nancy Andrews | M | 65 | 9 years | |
| Charles Sawyers | M | 65 | 11 years | |
| Robert Portman | M | 68 | 1 years | |
| Bill Winters | M | 62 | 11 years | |
| Carlo Rizzuto | M | 53 | 6 years | |
| Kimberly Blackwell | M | 55 | 3 years | |
| Rajesh Subramaniam | M | 58 | 2 years | |
| Wesley Bush | M | 63 | 5 years | |
| Steffen Lang | M | 57 | 7 years | |
| Shailesh Jejurikar | M | 57 | 35 years | |
| Jan Tighe | M | 61 | 1 years | |
| Ted Graham | M | - | 8 years | |
| Andre Schulten | M | 53 | 28 years | |
| Kenneth J. Dow | M | - | - | |
| Mindy Sherwood | F | 57 | 35 years | |
| Matthew Janzaruk | M | 50 | 21 years | |
| Christophe Mangin | M | - | - | |
| Sheila Bonini | F | 60 | 1 years | |
| Brent Pfeiffenberger | M | - | 1 years | |
| Judith Miscik | F | 65 | 6 years | |
| Marc M. P. de Garidel | M | 66 |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | 10 years |
| Debra Lee | F | 69 | 4 years | |
| Patricia Woertz | F | 71 | 16 years | |
| Cynthia Butitta | F | 70 | 3 years | |
| Angela Braly | F | 62 | 15 years | |
| Devin Wenig | M | 56 | 6 years | |
| Aneel Bhusri | M | 58 | 3 years | |
| Terry Lundgren | M | 72 | 11 years | |
| Patricia Russo | F | 71 | 15 years | |
| Ashley McEvoy | F | - | 1 years | |
| Thomas Schoewe | M | 71 | 13 years | |
| Stefan Oschmann | M | 66 |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | - |
| Timothy Walbert | M | 57 | 2 years | |
| Christine McCarthy | F | 69 | 5 years | |
| Christopher Hatto | M | 53 | 17 years | |
| John Bilbrey | M | 67 | 9 years | |
| Joanne Crevoiserat | F | 60 | 2 years | |
| Susan Whaley | F | - | 25 years | |
| Craig Glidden | M | 66 | 9 years | |
| Christopher Kempczinski | M | 55 | 3 years | |
| Mark Reuss | M | 59 | 41 years | |
| Ming Jian Kuo | M | 62 |
The Blackstone Group
 The Blackstone Group Investment ManagersFinance Part of Blackstone, Inc., The Blackstone Group enables leading energy companies to build enterprises at scale that can deliver clean, reliable and affordable energy to help meet needs. The company is based in Beijing, China. The Chinese company invests in companies shaping the future, helping emerging leaders become champions through the power of the Blackstone platform. | 17 years |
| Mark Pruzanski | M | 56 |
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Part of Eli Lilly & Co., Versanis Bio, Inc. is a clinical-stage biopharmaceutical company. The company is based in New York, NY. The company was founded by Lloyd Klickstein. Mark E. Pruzanski has been the CEO of the company since 2021. Versanis Bio was acquired by Eli Lilly & Co. on August 14, 2023 for $1,925 million. | 3 years |
| Jon McNeill McNeill | M | 56 | 2 years | |
| Liz Doherty | F | 67 | 8 years | |
| Ton Büchner | M | 59 | 8 years | |
| Linda Gooden | F | 70 | 9 years | |
| Hyam Levitsky | M | 66 | 5 years | |
| Jennifer Daniels | F | 60 | 10 years | |
| Charlotte Pamer-Wieser | M | - | 13 years | |
| Paul Jacobson | M | 52 | 4 years | |
| Kristen Siemen | F | - | 3 years | |
| Alan Wexler | M | 60 | 4 years | |
| Norman de Greve | M | - | 1 years | |
| Ian Read | M | 71 |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | - |
| Ian Ragan | M | - |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | - |
| John Roth | M | 55 | 4 years | |
| Andreas Fibig | M | 62 |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | - |
| Lin-Hua Wu | F | - | 1 years | |
| Ashish Kohli | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Taylor | M | 66 | 42 years | |
| Meg Whitman | F | 66 | 11 years | |
| Kent E. Helfrich | M | 58 | 7 years | |
| Dhivya Suryadevara | F | 44 | 5 years | |
| Matthew Tsien | M | 63 |
Stanford University
| 9 years |
| Daniel Ammann | M | 51 | 9 years | |
| Osvaldo Flores | M | - | - | |
| Henning I. Jakobsen | M | 62 | 9 years | |
| Stephen J. Fogarty | M | 74 | - | |
| Rolf M. Zinkernagel | M | 80 | 15 years | |
| Wendelin Wiedeking | M | 72 | 11 years | |
| Ulrich Lehner | M | 78 | 13 years | |
| Terri K. Maupin | F | 62 | 10 years | |
| George Scangos | M | 76 |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | 3 years |
| Sharon Wicker | F | 68 |
Heinz North America Consumer Products
 Heinz North America Consumer Products Food: Specialty/CandyConsumer Non-Durables Heinz North America Consumer Products manufactures snack foods. Its products include mustard and barbecue and pasta sauces that are sold under the Heinz 57, Jack Daniels, Classico pasta sauces, and Lea & Perrins Worcestershire brands. The company is located in Pittsburgh, PA. | 9 years |
| Dennis Reilley | M | 71 | 8 years | |
| Theodore Solso | M | 77 | 9 years | |
| Ernesto Zedillo Ponce de León | M | 71 | 18 years | |
| Scott Cook | M | 72 | 20 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 80 | 80.81% |
| Switzerland | 15 | 15.15% |
| Belgium | 6 | 6.06% |
| China | 1 | 1.01% |
| United Kingdom | 0 | -.--% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Joseph Jimenez
- Personal Network